img

Global Neuromuscular Blocking Drug Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Neuromuscular Blocking Drug Market Insights, Forecast to 2034

Neuromuscular blocking drugs cause paralysis of the affected skeletal muscles by blocking neuromuscular transmission at the neuromuscular junction.
Market Analysis and InsightsGlobal Neuromuscular Blocking Drug Market
Global Neuromuscular Blocking Drug market is expected to reach to US$ 3968 million in 2024, with a positive growth of %, compared with US$ 3815 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Neuromuscular Blocking Drug industry is evaluated to reach US$ 5079 million in 2029. The CAGR will be 4.2% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Neuromuscular Blocking Drug market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Neuromuscular Blocking Drug market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Hikma Pharmaceuticals
Merck
Novartis
Bayer
Pfizer
AbbVie
GSK
Segment by Type
Non-polarizing Agents
Depolarizing Agents

Segment by Application


Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Neuromuscular Blocking Drug introduction, etc. Neuromuscular Blocking Drug Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Neuromuscular Blocking Drug
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neuromuscular Blocking Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Non-polarizing Agents
1.2.3 Depolarizing Agents
1.3 Market by Application
1.3.1 Global Neuromuscular Blocking Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neuromuscular Blocking Drug Market Perspective (2018-2029)
2.2 Global Neuromuscular Blocking Drug Growth Trends by Region
2.2.1 Neuromuscular Blocking Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Neuromuscular Blocking Drug Historic Market Size by Region (2018-2024)
2.2.3 Neuromuscular Blocking Drug Forecasted Market Size by Region (2024-2029)
2.3 Neuromuscular Blocking Drug Market Dynamics
2.3.1 Neuromuscular Blocking Drug Industry Trends
2.3.2 Neuromuscular Blocking Drug Market Drivers
2.3.3 Neuromuscular Blocking Drug Market Challenges
2.3.4 Neuromuscular Blocking Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Neuromuscular Blocking Drug by Players
3.1.1 Global Neuromuscular Blocking Drug Revenue by Players (2018-2024)
3.1.2 Global Neuromuscular Blocking Drug Revenue Market Share by Players (2018-2024)
3.2 Global Neuromuscular Blocking Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Neuromuscular Blocking Drug, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Neuromuscular Blocking Drug Market Concentration Ratio
3.4.1 Global Neuromuscular Blocking Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neuromuscular Blocking Drug Revenue in 2022
3.5 Global Key Players of Neuromuscular Blocking Drug Head office and Area Served
3.6 Global Key Players of Neuromuscular Blocking Drug, Product and Application
3.7 Global Key Players of Neuromuscular Blocking Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Neuromuscular Blocking Drug Breakdown Data by Type
4.1 Global Neuromuscular Blocking Drug Historic Market Size by Type (2018-2024)
4.2 Global Neuromuscular Blocking Drug Forecasted Market Size by Type (2024-2029)
5 Neuromuscular Blocking Drug Breakdown Data by Application
5.1 Global Neuromuscular Blocking Drug Historic Market Size by Application (2018-2024)
5.2 Global Neuromuscular Blocking Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Neuromuscular Blocking Drug Market Size (2018-2029)
6.2 North America Neuromuscular Blocking Drug Market Size by Type
6.2.1 North America Neuromuscular Blocking Drug Market Size by Type (2018-2024)
6.2.2 North America Neuromuscular Blocking Drug Market Size by Type (2024-2029)
6.2.3 North America Neuromuscular Blocking Drug Market Share by Type (2018-2029)
6.3 North America Neuromuscular Blocking Drug Market Size by Application
6.3.1 North America Neuromuscular Blocking Drug Market Size by Application (2018-2024)
6.3.2 North America Neuromuscular Blocking Drug Market Size by Application (2024-2029)
6.3.3 North America Neuromuscular Blocking Drug Market Share by Application (2018-2029)
6.4 North America Neuromuscular Blocking Drug Market Size by Country
6.4.1 North America Neuromuscular Blocking Drug Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Neuromuscular Blocking Drug Market Size by Country (2018-2024)
6.4.3 North America Neuromuscular Blocking Drug Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Neuromuscular Blocking Drug Market Size (2018-2029)
7.2 Europe Neuromuscular Blocking Drug Market Size by Type
7.2.1 Europe Neuromuscular Blocking Drug Market Size by Type (2018-2024)
7.2.2 Europe Neuromuscular Blocking Drug Market Size by Type (2024-2029)
7.2.3 Europe Neuromuscular Blocking Drug Market Share by Type (2018-2029)
7.3 Europe Neuromuscular Blocking Drug Market Size by Application
7.3.1 Europe Neuromuscular Blocking Drug Market Size by Application (2018-2024)
7.3.2 Europe Neuromuscular Blocking Drug Market Size by Application (2024-2029)
7.3.3 Europe Neuromuscular Blocking Drug Market Share by Application (2018-2029)
7.4 Europe Neuromuscular Blocking Drug Market Size by Country
7.4.1 Europe Neuromuscular Blocking Drug Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Neuromuscular Blocking Drug Market Size by Country (2018-2024)
7.4.3 Europe Neuromuscular Blocking Drug Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Neuromuscular Blocking Drug Market Size (2018-2029)
8.2 China Neuromuscular Blocking Drug Market Size by Type
8.2.1 China Neuromuscular Blocking Drug Market Size by Type (2018-2024)
8.2.2 China Neuromuscular Blocking Drug Market Size by Type (2024-2029)
8.2.3 China Neuromuscular Blocking Drug Market Share by Type (2018-2029)
8.3 China Neuromuscular Blocking Drug Market Size by Application
8.3.1 China Neuromuscular Blocking Drug Market Size by Application (2018-2024)
8.3.2 China Neuromuscular Blocking Drug Market Size by Application (2024-2029)
8.3.3 China Neuromuscular Blocking Drug Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Neuromuscular Blocking Drug Market Size (2018-2029)
9.2 Asia Neuromuscular Blocking Drug Market Size by Type
9.2.1 Asia Neuromuscular Blocking Drug Market Size by Type (2018-2024)
9.2.2 Asia Neuromuscular Blocking Drug Market Size by Type (2024-2029)
9.2.3 Asia Neuromuscular Blocking Drug Market Share by Type (2018-2029)
9.3 Asia Neuromuscular Blocking Drug Market Size by Application
9.3.1 Asia Neuromuscular Blocking Drug Market Size by Application (2018-2024)
9.3.2 Asia Neuromuscular Blocking Drug Market Size by Application (2024-2029)
9.3.3 Asia Neuromuscular Blocking Drug Market Share by Application (2018-2029)
9.4 Asia Neuromuscular Blocking Drug Market Size by Region
9.4.1 Asia Neuromuscular Blocking Drug Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Neuromuscular Blocking Drug Market Size by Region (2018-2024)
9.4.3 Asia Neuromuscular Blocking Drug Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Neuromuscular Blocking Drug Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Neuromuscular Blocking Drug Market Size by Type
10.2.1 Middle East, Africa, and Latin America Neuromuscular Blocking Drug Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Neuromuscular Blocking Drug Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Neuromuscular Blocking Drug Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Neuromuscular Blocking Drug Market Size by Application
10.3.1 Middle East, Africa, and Latin America Neuromuscular Blocking Drug Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Neuromuscular Blocking Drug Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Neuromuscular Blocking Drug Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Neuromuscular Blocking Drug Market Size by Country
10.4.1 Middle East, Africa, and Latin America Neuromuscular Blocking Drug Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Neuromuscular Blocking Drug Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Neuromuscular Blocking Drug Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Hikma Pharmaceuticals
11.1.1 Hikma Pharmaceuticals Company Details
11.1.2 Hikma Pharmaceuticals Business Overview
11.1.3 Hikma Pharmaceuticals Neuromuscular Blocking Drug Introduction
11.1.4 Hikma Pharmaceuticals Revenue in Neuromuscular Blocking Drug Business (2018-2024)
11.1.5 Hikma Pharmaceuticals Recent Developments
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Neuromuscular Blocking Drug Introduction
11.2.4 Merck Revenue in Neuromuscular Blocking Drug Business (2018-2024)
11.2.5 Merck Recent Developments
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Neuromuscular Blocking Drug Introduction
11.3.4 Novartis Revenue in Neuromuscular Blocking Drug Business (2018-2024)
11.3.5 Novartis Recent Developments
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Bayer Business Overview
11.4.3 Bayer Neuromuscular Blocking Drug Introduction
11.4.4 Bayer Revenue in Neuromuscular Blocking Drug Business (2018-2024)
11.4.5 Bayer Recent Developments
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Neuromuscular Blocking Drug Introduction
11.5.4 Pfizer Revenue in Neuromuscular Blocking Drug Business (2018-2024)
11.5.5 Pfizer Recent Developments
11.6 AbbVie
11.6.1 AbbVie Company Details
11.6.2 AbbVie Business Overview
11.6.3 AbbVie Neuromuscular Blocking Drug Introduction
11.6.4 AbbVie Revenue in Neuromuscular Blocking Drug Business (2018-2024)
11.6.5 AbbVie Recent Developments
11.7 GSK
11.7.1 GSK Company Details
11.7.2 GSK Business Overview
11.7.3 GSK Neuromuscular Blocking Drug Introduction
11.7.4 GSK Revenue in Neuromuscular Blocking Drug Business (2018-2024)
11.7.5 GSK Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Neuromuscular Blocking Drug Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Non-polarizing Agents
Table 3. Key Players of Depolarizing Agents
Table 4. Global Neuromuscular Blocking Drug Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Neuromuscular Blocking Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Neuromuscular Blocking Drug Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Neuromuscular Blocking Drug Market Share by Region (2018-2024)
Table 8. Global Neuromuscular Blocking Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Neuromuscular Blocking Drug Market Share by Region (2024-2029)
Table 10. Neuromuscular Blocking Drug Market Trends
Table 11. Neuromuscular Blocking Drug Market Drivers
Table 12. Neuromuscular Blocking Drug Market Challenges
Table 13. Neuromuscular Blocking Drug Market Restraints
Table 14. Global Neuromuscular Blocking Drug Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Neuromuscular Blocking Drug Revenue Share by Players (2018-2024)
Table 16. Global Top Neuromuscular Blocking Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuromuscular Blocking Drug as of 2022)
Table 17. Global Neuromuscular Blocking Drug Industry Ranking 2021 VS 2022 VS 2024
Table 18. Global 5 Largest Players Market Share by Neuromuscular Blocking Drug Revenue (CR5 and HHI) & (2018-2024)
Table 19. Global Key Players of Neuromuscular Blocking Drug, Headquarters and Area Served
Table 20. Global Key Players of Neuromuscular Blocking Drug, Product and Application
Table 21. Global Key Players of Neuromuscular Blocking Drug, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Neuromuscular Blocking Drug Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Neuromuscular Blocking Drug Revenue Market Share by Type (2018-2024)
Table 25. Global Neuromuscular Blocking Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Neuromuscular Blocking Drug Revenue Market Share by Type (2024-2029)
Table 27. Global Neuromuscular Blocking Drug Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Neuromuscular Blocking Drug Revenue Share by Application (2018-2024)
Table 29. Global Neuromuscular Blocking Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Neuromuscular Blocking Drug Revenue Share by Application (2024-2029)
Table 31. North America Neuromuscular Blocking Drug Market Size by Type (2018-2024) & (US$ Million)
Table 32. North America Neuromuscular Blocking Drug Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Neuromuscular Blocking Drug Market Size by Application (2018-2024) & (US$ Million)
Table 34. North America Neuromuscular Blocking Drug Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Neuromuscular Blocking Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Neuromuscular Blocking Drug Market Size by Country (2018-2024) & (US$ Million)
Table 37. North America Neuromuscular Blocking Drug Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Neuromuscular Blocking Drug Market Size by Type (2018-2024) & (US$ Million)
Table 39. Europe Neuromuscular Blocking Drug Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Neuromuscular Blocking Drug Market Size by Application (2018-2024) & (US$ Million)
Table 41. Europe Neuromuscular Blocking Drug Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Neuromuscular Blocking Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Neuromuscular Blocking Drug Market Size by Country (2018-2024) & (US$ Million)
Table 44. Europe Neuromuscular Blocking Drug Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Neuromuscular Blocking Drug Market Size by Type (2018-2024) & (US$ Million)
Table 46. China Neuromuscular Blocking Drug Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Neuromuscular Blocking Drug Market Size by Application (2018-2024) & (US$ Million)
Table 48. China Neuromuscular Blocking Drug Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Neuromuscular Blocking Drug Market Size by Type (2018-2024) & (US$ Million)
Table 50. Asia Neuromuscular Blocking Drug Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Neuromuscular Blocking Drug Market Size by Application (2018-2024) & (US$ Million)
Table 52. Asia Neuromuscular Blocking Drug Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Neuromuscular Blocking Drug Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Neuromuscular Blocking Drug Market Size by Region (2018-2024) & (US$ Million)
Table 55. Asia Neuromuscular Blocking Drug Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Neuromuscular Blocking Drug Market Size by Type (2018-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Neuromuscular Blocking Drug Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Neuromuscular Blocking Drug Market Size by Application (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Neuromuscular Blocking Drug Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Neuromuscular Blocking Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Neuromuscular Blocking Drug Market Size by Country (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Neuromuscular Blocking Drug Market Size by Country (2024-2029) & (US$ Million)
Table 63. Hikma Pharmaceuticals Company Details
Table 64. Hikma Pharmaceuticals Business Overview
Table 65. Hikma Pharmaceuticals Neuromuscular Blocking Drug Product
Table 66. Hikma Pharmaceuticals Revenue in Neuromuscular Blocking Drug Business (2018-2024) & (US$ Million)
Table 67. Hikma Pharmaceuticals Recent Developments
Table 68. Merck Company Details
Table 69. Merck Business Overview
Table 70. Merck Neuromuscular Blocking Drug Product
Table 71. Merck Revenue in Neuromuscular Blocking Drug Business (2018-2024) & (US$ Million)
Table 72. Merck Recent Developments
Table 73. Novartis Company Details
Table 74. Novartis Business Overview
Table 75. Novartis Neuromuscular Blocking Drug Product
Table 76. Novartis Revenue in Neuromuscular Blocking Drug Business (2018-2024) & (US$ Million)
Table 77. Novartis Recent Developments
Table 78. Bayer Company Details
Table 79. Bayer Business Overview
Table 80. Bayer Neuromuscular Blocking Drug Product
Table 81. Bayer Revenue in Neuromuscular Blocking Drug Business (2018-2024) & (US$ Million)
Table 82. Bayer Recent Developments
Table 83. Pfizer Company Details
Table 84. Pfizer Business Overview
Table 85. Pfizer Neuromuscular Blocking Drug Product
Table 86. Pfizer Revenue in Neuromuscular Blocking Drug Business (2018-2024) & (US$ Million)
Table 87. Pfizer Recent Developments
Table 88. AbbVie Company Details
Table 89. AbbVie Business Overview
Table 90. AbbVie Neuromuscular Blocking Drug Product
Table 91. AbbVie Revenue in Neuromuscular Blocking Drug Business (2018-2024) & (US$ Million)
Table 92. AbbVie Recent Developments
Table 93. GSK Company Details
Table 94. GSK Business Overview
Table 95. GSK Neuromuscular Blocking Drug Product
Table 96. GSK Revenue in Neuromuscular Blocking Drug Business (2018-2024) & (US$ Million)
Table 97. GSK Recent Developments
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neuromuscular Blocking Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Neuromuscular Blocking Drug Market Share by Type: 2022 VS 2029
Figure 3. Non-polarizing Agents Features
Figure 4. Depolarizing Agents Features
Figure 5. Global Neuromuscular Blocking Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Neuromuscular Blocking Drug Market Share by Application: 2022 VS 2029
Figure 7. Hospital Pharmacy Case Studies
Figure 8. Retail Pharmacy Case Studies
Figure 9. Online Pharmacy Case Studies
Figure 10. Others Case Studies
Figure 11. Neuromuscular Blocking Drug Report Years Considered
Figure 12. Global Neuromuscular Blocking Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Neuromuscular Blocking Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Neuromuscular Blocking Drug Market Share by Region: 2022 VS 2029
Figure 15. Global Neuromuscular Blocking Drug Market Share by Players in 2022
Figure 16. Global Top Neuromuscular Blocking Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuromuscular Blocking Drug as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Neuromuscular Blocking Drug Revenue in 2022
Figure 18. North America Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Neuromuscular Blocking Drug Market Share by Type (2018-2029)
Figure 20. North America Neuromuscular Blocking Drug Market Share by Application (2018-2029)
Figure 21. North America Neuromuscular Blocking Drug Market Share by Country (2018-2029)
Figure 22. United States Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Neuromuscular Blocking Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 25. Europe Neuromuscular Blocking Drug Market Share by Type (2018-2029)
Figure 26. Europe Neuromuscular Blocking Drug Market Share by Application (2018-2029)
Figure 27. Europe Neuromuscular Blocking Drug Market Share by Country (2018-2029)
Figure 28. Germany Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. France Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. U.K. Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Italy Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Russia Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Nordic Countries Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. China Neuromuscular Blocking Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 35. China Neuromuscular Blocking Drug Market Share by Type (2018-2029)
Figure 36. China Neuromuscular Blocking Drug Market Share by Application (2018-2029)
Figure 37. Asia Neuromuscular Blocking Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 38. Asia Neuromuscular Blocking Drug Market Share by Type (2018-2029)
Figure 39. Asia Neuromuscular Blocking Drug Market Share by Application (2018-2029)
Figure 40. Asia Neuromuscular Blocking Drug Market Share by Region (2018-2029)
Figure 41. Japan Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. South Korea Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. China Taiwan Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Southeast Asia Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. India Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Australia Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Neuromuscular Blocking Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Neuromuscular Blocking Drug Market Share by Type (2018-2029)
Figure 49. Middle East, Africa, and Latin America Neuromuscular Blocking Drug Market Share by Application (2018-2029)
Figure 50. Middle East, Africa, and Latin America Neuromuscular Blocking Drug Market Share by Country (2018-2029)
Figure 51. Brazil Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Mexico Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Turkey Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Israel Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. GCC Countries Neuromuscular Blocking Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Hikma Pharmaceuticals Revenue Growth Rate in Neuromuscular Blocking Drug Business (2018-2024)
Figure 58. Merck Revenue Growth Rate in Neuromuscular Blocking Drug Business (2018-2024)
Figure 59. Novartis Revenue Growth Rate in Neuromuscular Blocking Drug Business (2018-2024)
Figure 60. Bayer Revenue Growth Rate in Neuromuscular Blocking Drug Business (2018-2024)
Figure 61. Pfizer Revenue Growth Rate in Neuromuscular Blocking Drug Business (2018-2024)
Figure 62. AbbVie Revenue Growth Rate in Neuromuscular Blocking Drug Business (2018-2024)
Figure 63. GSK Revenue Growth Rate in Neuromuscular Blocking Drug Business (2018-2024)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries